Fifteen years after the $246 billion tobacco legal settlements were reached most states are not spending much on tobacco cessation, U.S. researchers say. Tobacco use is the top cause of preventable U.S. death, killing more than 400,000 ...
Smoking alters several genes associated with health problems for smokers, such as increased risk for cancer and diabetes, researchers in Sweden say. A study, published in the journal Human Molecular Genetics, identified a large number of ...
US-based privately-held therapeutic antibody firm AnaptysBio has commenced an antibody development program with Momenta Pharmaceuticals, focused on the development of new antibodies against a therapeutically relevant target. Both the ...
Merck Serono has signed a license agreement with the Spanish National Cancer Research Centre (CNIO) in Madrid in the area of cancer drug development and will build upon CNIO research discoveries to support the development and ...
Tags: Cancer Patients, Merck Serono
In two separate clinical trials, researchers at Albert Einstein College of Medicine of Yeshiva University have found that periodic meetings with a lactation consultant encourages women traditionally resistant to breastfeeding to do so, at ...
Navidea Biopharmaceuticals has submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for the approval to market and sale Lymphoseek Injection for sentinel lymph node (SLN) detection in patients ...
A novel microfluidics device by IBM could be a boon to the oncology market. The new device can assist oncologists in identifying different types of cancer, offering several improvements over existing biopsy techniques. When a patient has ...
Tags: Health, Medicine, Microfluidics Device
Two published studies and an accompanying editorial in the Annals of Internal Medicine say there is no clear benefit for most to consume vitamin supplements. Eliseo Guallar of the Johns Hopkins Bloomberg School of Public Health in ...
Tags: dietary supplements, eating plan, disease
US-based Seno Medical Instruments has announced new statistical analysis of outcomes from a feasibility study of its investigational Imagio breast imaging device. The analysis of data from the feasibility study, presented at the San ...
The Toronto Transportation Club (TTC) put down their razors for the month of November to support men's health. The month long "Movember" challenge strives to bring men's health, particulary mental health and prostrate cancer awareness, to ...
Tags: Toronto Transportation Club, men's health, Movember, Movember challenge
Metabolism was lost in the shadows of cancer research for decades but has recently been reclaiming some of the spotlight. Now, Mina Bissell, Distinguished Scientist with Berkeley Lab's Life Sciences Division and a leading authority on ...
Investors apparently like the potential for the ViewRay system — a combo of simultaneous MRI and radiation therapy delivery that has already been acquired by major five cancer treatment centers worldwide. Cleveland–based ...
Ventana Medical Systems (Ventana), a member of the Roche Group, has announced that its Ventana HER2/neu (4B5) rabbit monoclonal primary antibody assay is now a companion diagnostic for detecting HER2 protein expression for patients who, in ...
Tags: Ventana, Medical Systems
NanoString Technologies has announced new results from a combined analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Trans-Arimidex, Tamoxifen, Alone or in Combination (TransATAC) studies. These results, which ...
Nucletron has announced that the first Esteya electronic brachytherapy system in the US has been installed at New York's Memorial Sloan-Kettering Cancer Center. Esteya by Nucletron, an Elekta company, is a new approach for skin cancer ...
Tags: Nucletron, Skin Cancer